Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Prinz

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|October 29, 2011
Cost-effectiveness evaluation of clobetasol propionate shampoo (CPS) maintenance in patients with moderate scalp psoriasis: a Pan-European analysisK Papp, Y Poulin, K Barber, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 21, 2014
Clinical relevance of immunogenicity of biologics in psoriasis: implications for treatment strategiesJ-M Carrascosa, M B A van Doorn, M Lahfa, et al.
Dermatology (Basel, Switzerland)|June 5, 2004
T-cell modulation for the treatment of chronic plaque psoriasis with efalizumab (Raptiva): mechanisms of actionD Jullien, J C Prinz, R G B Langley, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 16, 2010
Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trialJ C Prinz, O Fitzgerald, R I Boggs, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 31, 2013
Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasisR Strohal, B Kirby, L Puig, et al.
The Journal of Experimental Medicine|April 1, 1990
Expression of the Fc-receptor for IgE (Fc epsilon RII, CD23) on alveolar macrophages in extrinsic allergic alveolitisA Pforte, G Breyer, J C Prinz, et al.
The Journal of Experimental Medicine|July 1, 1989
Induction of Fc epsilon R2/CD23 on human epidermal Langerhans cells by human recombinant interleukin 4 and gamma interferonT Bieber, A Rieger, C Neuchrist, et al.
The British Journal of Dermatology|August 19, 2014
Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE)A Blauvelt, J C Prinz, A B Gottlieb, et al.
The British Journal of Dermatology|October 14, 2014
Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-upR G Langley, M Lebwohl, G G Krueger, et al.
The British Journal of Dermatology|July 13, 2021
Lesional activation of T<sub>c</sub> 17 cells in Behçet disease and psoriasis supports HLA class I-mediated autoimmune responsesS Vural, K Kerl, P Ertop Doğan, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Journal of the European Academy of Dermatology and Venereology : JEADV|October 29, 2011
Cost-effectiveness evaluation of clobetasol propionate shampoo (CPS) maintenance in patients with moderate scalp psoriasis: a Pan-European analysisK Papp, Y Poulin, K Barber, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 21, 2014
Clinical relevance of immunogenicity of biologics in psoriasis: implications for treatment strategiesJ-M Carrascosa, M B A van Doorn, M Lahfa, et al.
Dermatology (Basel, Switzerland)|June 5, 2004
T-cell modulation for the treatment of chronic plaque psoriasis with efalizumab (Raptiva): mechanisms of actionD Jullien, J C Prinz, R G B Langley, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 16, 2010
Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trialJ C Prinz, O Fitzgerald, R I Boggs, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 31, 2013
Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasisR Strohal, B Kirby, L Puig, et al.
The Journal of Experimental Medicine|April 1, 1990
Expression of the Fc-receptor for IgE (Fc epsilon RII, CD23) on alveolar macrophages in extrinsic allergic alveolitisA Pforte, G Breyer, J C Prinz, et al.
The Journal of Experimental Medicine|July 1, 1989
Induction of Fc epsilon R2/CD23 on human epidermal Langerhans cells by human recombinant interleukin 4 and gamma interferonT Bieber, A Rieger, C Neuchrist, et al.
The British Journal of Dermatology|August 19, 2014
Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE)A Blauvelt, J C Prinz, A B Gottlieb, et al.
The British Journal of Dermatology|October 14, 2014
Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-upR G Langley, M Lebwohl, G G Krueger, et al.
The British Journal of Dermatology|July 13, 2021
Lesional activation of T<sub>c</sub> 17 cells in Behçet disease and psoriasis supports HLA class I-mediated autoimmune responsesS Vural, K Kerl, P Ertop Doğan, et al.
Pageof 7